Zevra Therapeutics Income Statement (2014-2025) | ZVRA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	-0.10M	-0.70M	-0.17M	-0.63M	-0.63M	-0.65M	-0.69M	-0.70M	-1.15M	-1.48M	-1.44M	-1.44M	-1.42M	-1.37M	-1.24M	-1.23M	-1.23M	11.46M	1.38M	2.09M	6.91M	1.93M	2.37M	12.12M	11.99M	1.97M	2.58M	3.96M	1.30M	2.87M	2.02M	3.18M	8.47M	2.90M	12.92M	3.42M	4.45M	3.70M	12.01M	20.40M	25.90M	26.10M
Cost of Revenue																		1.00M							1.00M		0.06M	0.01M	0.05M	0.14M	0.02M	0.12M	0.68M	0.14M	1.23M	0.17M	3.57M	2.30M	1.37M	1.34M	12.38M	1.24M
Gross Profit																		10.46M							10.99M		2.52M	3.96M	1.25M	2.73M	2.00M	3.05M	7.79M	2.75M	11.69M	3.25M	0.88M	1.40M	10.65M	19.06M	13.52M	24.86M
Operating items
Amortization - Intangibles																																			0.77M	1.53M	1.55M	1.54M	1.62M	1.61M	1.62M	0.32M
Research & Development	1.04M	1.72M	3.25M	5.91M	2.12M	2.77M	4.33M	4.72M	3.23M	4.99M	4.29M	11.64M	10.49M	13.33M	6.30M	8.53M	4.80M	3.62M	2.46M	2.13M	1.95M	1.71M	3.05M	2.27M	2.85M	2.24M	2.81M	3.08M	4.79M	5.38M	6.54M	8.65M	7.43M	12.30M	11.42M	12.28M	10.52M	10.95M	8.35M	3.26M	3.43M	3.43M
Selling, General & Administrative	0.53M	1.33M	1.09M	1.58M	0.98M	3.19M	2.15M	2.57M	3.74M	4.29M	3.10M	3.13M	3.42M	2.99M	2.96M	2.84M	2.99M	3.61M	1.38M	2.25M	1.72M	1.43M	2.53M	1.89M	2.31M	1.95M	2.56M	2.73M	3.58M	4.02M	4.70M	7.23M	6.61M	5.82M	14.66M	9.93M	12.60M	16.21M	16.12M	19.55M	20.78M	16.93M
Other Operating Expenses											3.01M			1.64M				1.00M	1.95M	1.49M	0.64M		-0.00M	1.00M	1.00M		0.06M	0.01M	17.69M	0.09M	0.09M			-25.90M	-24.11M	-20.65M
Operating Expenses	1.57M	3.04M	4.34M	7.49M	3.10M	5.96M	6.48M	7.28M	6.97M	9.28M	10.40M	14.77M	13.91M	17.96M	9.27M	11.37M	7.79M	8.23M	5.79M	5.86M	4.32M	3.14M	5.58M	5.16M	6.15M	4.19M	5.42M	5.82M	26.07M	9.50M	11.34M	15.88M	14.04M	18.11M	26.08M	22.21M	23.12M	27.15M	24.48M	22.80M	24.21M	20.37M
Operating Income	-1.57M	-3.04M	-4.34M	-7.49M	-3.10M	-5.96M	-6.48M	-7.28M	-6.97M	-9.28M	-10.40M	-14.77M	-13.91M	-17.96M	-9.27M	-11.37M	-7.79M	3.23M	-4.41M	-3.77M	2.59M	-1.21M	-3.21M	6.96M	5.83M	-2.22M	-2.84M	-1.86M	-24.82M	-6.75M	-9.14M	-12.83M	-6.25M	-15.36M	-15.16M	-20.49M	-23.80M	-27.31M	-15.42M	-5.36M	-71.04M	4.14M
EBIT	-1.57M	-3.04M	-4.34M	-7.49M	-3.10M	-5.96M	-6.48M	-7.28M	-6.97M	-9.28M	-10.40M	-14.77M	-13.91M	-17.96M	-9.27M	-11.37M	-7.79M	3.23M	-4.41M	-3.77M	2.59M	-1.21M	-3.21M	6.96M	5.83M	-2.22M	-2.84M	-1.86M	-24.82M	-6.75M	-9.14M	-12.83M	-6.25M	-15.36M	-15.16M	-20.49M	-23.80M	-27.31M	-15.42M	-5.36M	-71.04M	4.14M
Non-operating items
Interest & Investment Income			0.00M	0.00M		0.00M	0.01M	0.01M	0.10M	0.14M	0.10M	0.12M	0.12M	0.05M	0.13M	0.15M	0.08M	0.06M	0.01M	-0.22M	0.04M	0.05M	0.22M	0.01M	-0.01M	0.14M	0.12M	0.11M	1.12M	0.22M	0.28M	1.04M	1.55M	1.74M	0.21M	0.93M	0.27M	1.05M	-0.07M	0.54M	2.38M	2.31M
Other Non Operating Income									-4.74M						4.74M									-16.89M	0.79M											-3.63M	1.79M	-6.74M	7.53M	-3.38M	135.35M	-6.56M
Non Operating Income	-0.34M	-0.53M	-2.84M	-4.33M	-2.87M	-23.79M	-3.24M	-1.92M	4.05M	19.04M	-3.03M	-11.46M	3.88M	2.83M	4.07M	-0.93M	-1.47M	-0.17M	-1.64M	-1.98M	-1.73M	-1.83M	-1.64M	-17.26M	0.37M	0.46M	0.17M	12.35M	2.88M	-5.60M	6.11M	-0.49M	3.60M	5.17M	-4.74M	3.79M	3.94M	-5.92M	-4.95M	3.44M	147.94M	-5.12M
Net income details
EBT	-1.91M	-3.58M	-7.17M	-11.81M	-5.97M	-29.74M	-9.72M	-9.20M	-2.92M	9.76M	-13.43M	-26.23M	-10.03M	-15.13M	-5.20M	-12.30M	-9.27M	3.07M	-6.04M	-5.75M	0.86M	-3.04M	-4.86M	-10.30M	6.20M	-1.76M	-2.67M	12.35M	-24.76M	-12.35M	6.47M	-13.32M	-2.65M	-10.19M	-19.89M	-16.69M	-19.86M	-33.23M	-20.37M	-1.92M	76.91M	-0.98M
Tax Provisions	-0.01M	-0.01M	-0.04M	0.03M	0.01M		0.02M	-0.00M	0.01M	-0.00M	-0.02M	-0.01M	-0.04M	-0.06M	-0.02M	-0.01M	-0.01M	0.00M	-0.01M			-0.03M					0.03M	-0.00M	0.75M	-0.03M	-0.79M	-0.10M	-0.07M	0.18M		-0.07M	0.07M		15.37M	1.18M	2.20M	-0.43M
Profit After Tax	-1.91M	-3.57M	-7.14M	-11.84M	-5.97M	-29.74M	-9.74M	-9.20M	-2.93M	9.77M	-13.41M	-26.22M	-9.99M	-15.07M	-5.18M	-12.29M	-9.26M	3.06M	-6.04M	-5.75M	0.86M	-3.01M	-4.86M	-10.30M	6.20M	-1.76M	-2.70M	12.35M	-24.04M	-12.32M	5.75M	-13.22M	-2.57M	-10.37M	-19.85M	-16.62M	-19.93M	-33.23M	-35.74M	-3.10M	74.71M	-0.54M
Income from Continuing Operations	-1.91M	-3.57M	-7.14M	-11.84M	-5.97M	-29.74M	-9.74M	-9.20M	-2.93M	9.77M	-13.41M	-26.22M	-9.99M	-15.07M	-5.18M	-12.29M	-9.26M	3.06M	-6.04M	-5.75M	0.86M	-3.01M	-4.86M	-10.30M	6.20M	-1.76M	-2.70M	12.35M	-25.51M	-12.32M	7.25M	-13.22M	-2.57M	-10.37M	-19.89M	-16.62M	-19.93M	-33.23M	-35.74M	-3.10M	74.71M	-0.54M
Consolidated Net Income	-1.91M	-3.57M	-7.14M	-11.84M	-5.97M	-29.74M	-9.74M	-9.20M	-2.93M	9.77M	-13.41M	-26.22M	-9.99M	-15.07M	-5.18M	-12.29M	-9.26M	3.06M	-6.04M	-5.75M	0.86M	-3.01M	-4.86M	-10.30M	6.20M	-1.76M	-2.70M	12.35M	-25.51M	-12.32M	7.25M	-13.22M	-2.57M	-10.37M	-19.89M	-16.62M	-19.93M	-33.23M	-35.74M	-3.10M	74.71M	-0.54M
Income towards Parent Company	-1.91M	-3.57M	-7.14M	-11.84M	-5.97M	-29.74M	-9.74M	-9.20M	-2.93M	9.77M	-13.41M	-26.22M	-9.99M	-15.07M	-5.18M	-12.29M	-9.26M	3.06M	-6.04M	-5.75M	0.86M	-3.01M	-4.86M	-10.30M	6.20M	-1.76M	-2.70M	12.35M	-25.51M	-12.32M	7.25M	-13.22M	-2.57M	-10.37M	-19.89M	-16.62M	-19.93M	-33.23M	-35.74M	-3.10M	74.71M	-0.54M
Preferred Dividend Payments																								37.44M	16.90M
Net Income towards Common Stockholders	-1.91M	-3.57M	-7.14M	-11.84M	-5.97M	-29.74M	-9.74M	-9.20M	-2.93M	9.77M	-13.41M	-26.22M	-15.12M	-15.07M	-5.18M	-12.29M	-9.26M	1.91M	-6.04M	-5.75M	0.86M	-3.01M	-4.86M	-47.74M	-10.70M	-1.76M	-2.70M	-1.86M	-24.04M	-6.62M	-9.02M	-11.77M	-2.57M	-10.37M	-19.89M	-16.62M	-19.93M	-33.23M	-35.74M	-3.10M	74.71M	-0.54M
Additional items
EPS (Basic)	-0.80	-1.50	-3.00	-4.97	-2.50	-2.45	-0.68	-0.64	-0.20	0.59	-0.92	-1.77	-0.65	-0.94	0.18	-0.46	-0.33	0.09	-12.58	3.00M	0.21	-0.68	-1.13	-2.49	-0.40	-0.05	0.05	0.35	-0.70	-0.36	0.16	-0.38	-0.08	-0.30	-0.54	-0.40	-0.48	-0.69	-0.69	-0.06	1.24	-0.01
EPS (Weighted Average and Diluted)						-2.46				-0.58			-1.50	-0.94			-0.45	0.06		-1.92	0.21	-0.68	-1.13	-2.49	-0.40	-0.06	0.05										-0.39	-0.69			-0.05	-0.01
Shares Outstanding (Weighted Average)				0.77M	0.77M	0.89M	0.90M	0.90M	0.91M	0.92M	0.92M	0.94M	0.95M	1.00M	1.65M	1.65M	1.78M	1.86M	2.08M	3.17M	4.11M	4.53M	4.53M	28.38M	28.51M	35.15M	35.32M	34.42M	34.42M	34.49M	34.50M	34.54M	33.88M	33.93M	36.22M	36.22M	41.85M	52.62M	53.38M	54.12M	54.68M	56.14M
Shares Outstanding (Diluted Average)														16.03M			28.39M	31.67M			63.16M																41.90M	47.81M			56.33M	56.78M
EBITDA	-1.57M	-3.04M	-4.34M	-7.49M	-3.10M	-5.96M	-6.48M	-7.28M	-6.97M	-9.28M	-10.40M	-14.77M	-13.91M	-17.96M	-9.27M	-11.37M	-7.79M	3.23M	-4.41M	-3.77M	2.59M	-1.21M	-3.21M	6.96M	5.83M	-2.22M	-2.84M	-1.86M	-24.82M	-6.75M	-9.14M	-12.83M	-6.25M	-15.36M	-15.16M	-20.49M	-23.80M	-27.31M	-15.42M	-5.36M	-71.04M	4.14M
Interest Expenses	0.10M	0.70M	0.17M	0.63M	0.63M	0.65M	0.69M	0.70M	1.15M	1.48M	1.44M	1.44M	1.42M	1.37M	1.24M	1.23M	1.23M	1.21M	1.19M	1.26M	1.20M	1.16M	1.17M	0.20M	0.02M	0.01M	0.01M	0.01M	0.04M	0.12M	0.17M	0.18M	0.20M	0.37M	0.76M	0.73M	2.11M	2.31M	2.19M	1.97M	2.01M	2.05M
Tax Rate	0.26%	0.17%	0.53%					0.01%			0.14%	0.03%	0.39%	0.40%	0.37%	0.07%	0.10%	0.10%	0.13%			1.12%								0.27%		0.77%	2.80%			0.42%					2.86%	44.32%

Research Tools

Zevra Therapeutics Income Statement (2014-2025) | ZVRA

Create an account

Sign In

Reset Password

Get Pro for 60% off